Work

Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2005.11.071

Authors: William T. Abraham, Alireza A. Shamshirsaz, Kim McFann, Ron M. Oren, Robert W. Schrier

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, University of Iowa Hospitals and Clinics

Language: English

Topic: Electrolyte and hormonal disorders

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1974987609

FWCI: 15.6

Cites: 28

Cited by: 130

Related to: 10